GeoVax Labs

GOVXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.670 M

$0.36 +1.28%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$21.5M

Loss-making

Shares outstanding

7,369,243

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#474Shuttle PharmaceuticalsSHPH$3.86M
#475Galmed PharmaceuticalsEOCN$3.78M
#476GeoVax LabsGOVX$3.67M
#47760 Degrees PharmaceuticalsSXTP$3.66M
#478PMGCELAB$3.45M

What if GeoVax Labs were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,992,612

Per share 8,237,302× higher

Bitcoin $1.74T

$172,392.09

Per share 474,517× higher

Nvidia $5.52T

$545,960.36

Per share 1,502,781× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for GeoVax Labs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.